Reduced transfer of tetanus antibodies with placental malaria
References (10)
- et al.
The human materno-foetal relationship in malaria: histological, ultrastructural and immunopathological studies of the placenta
Trans R Soc Trop Med Hyg
(1980) - et al.
The influence of malaria and gestation on the immune response to one and two doses of absorbed tetanus toxoid in pregnancy
Bull WHO
(1984) - et al.
Neonatal tetanus in New Guinea
BMJ
(1961) - et al.
The use of toxoid for prevention of tetanus neonatorum
Bull WHO
(1966)
Cited by (105)
Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries
2022, VaccineCitation Excerpt :Understanding the independent effects of HIV, placental malaria, and hypergammaglobulinemia is complicated by the geographic prevalence of these conditions. Previous studies of HIV and placental malaria did not measure total maternal IgG [62] or were unable to distinguish the conditions due to high prevalence of both conditions in the study populations (overall and within individuals) [22,49]. This was not the case in a more recent study of 300 mother-full-term-infant pairs in Papua New Guinea [25].
Immune system: development and acquisition of immunological competence
2021, Jornal de PediatriaCitation Excerpt :Some factors are known to be associated with a reduction in transplacental antibody transport. Among them, the following are noteworthy: maternal concentrations of total IgG, especially above 15 g/L20–22; prematurity11, low birth weight11, placental malaria infection22,23, and maternal HIV infection21,22,24. After birth, maternal antibodies decline.
Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women
2019, CellCitation Excerpt :In normal pregnancies, infant cord blood IgG levels can reach levels >100% compared to those of their mothers (Kohler and Farr, 1966; Malek et al., 1996; Palmeira et al., 2012; Tatra and Placheta, 1979). In contrast, maternal infectious diseases can impair the placental transfer of IgG to the fetus (Brair et al., 1994; Bulmer et al., 1993; Fried et al., 1998). A number of studies have independently confirmed that, compared to uninfected women, HIV-infected women have impaired placental IgG transfer efficiency (Cumberland et al., 2007; Dangor et al., 2015; de Moraes-Pinto et al., 1993, 1996, 1998; Fu et al., 2016; Gupta et al., 2014; Le Doare et al., 2015; Scott et al., 2005).
Immunobiological aspects of vaccines in pregnancy: Maternal perspective
2019, Maternal ImmunizationConclusion
2019, Maternal Immunization